3-196318096-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_152773.5(DYNLT2B):c.57G>A(p.Glu19=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000483 in 1,567,116 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00025 ( 2 hom. )
Consequence
DYNLT2B
NM_152773.5 synonymous
NM_152773.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.117
Genes affected
DYNLT2B (HGNC:28482): (dynein light chain Tctex-type 2B) Dyneins are a group of microtubule-activated ATPases that function as molecular motors. They are divided into two subgroups of axonemal and cytoplasmic dyneins. The cytoplasmic dyneins function in intracellular motility, including retrograde axonal transport, protein sorting, organelle movement, and spindle dynamics. Molecules of conventional cytoplasmic dynein are comprised of 2 heavy chain polypeptides and a number of intermediate and light chains. This gene encodes a subunit of the human cytoplasmic dynein-2 complex. Mutations in this gene are associated with short-rib thoracic dysplasia 17 with or without polydactyly. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 3-196318096-C-T is Benign according to our data. Variant chr3-196318096-C-T is described in ClinVar as [Benign]. Clinvar id is 779236.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.117 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DYNLT2B | NM_152773.5 | c.57G>A | p.Glu19= | synonymous_variant | 1/5 | ENST00000325318.10 | |
TM4SF19-DYNLT2B | NR_037950.1 | n.862-1865G>A | intron_variant, non_coding_transcript_variant | ||||
DYNLT2B | NM_001351628.2 | c.57G>A | p.Glu19= | synonymous_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DYNLT2B | ENST00000325318.10 | c.57G>A | p.Glu19= | synonymous_variant | 1/5 | 1 | NM_152773.5 | P1 | |
DYNLT2B | ENST00000446494.1 | c.57G>A | p.Glu19= | synonymous_variant, NMD_transcript_variant | 1/6 | 3 | |||
DYNLT2B | ENST00000426563.5 | c.57G>A | p.Glu19= | synonymous_variant, NMD_transcript_variant | 1/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00266 AC: 404AN: 152070Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
404
AN:
152070
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000473 AC: 96AN: 202772Hom.: 0 AF XY: 0.000333 AC XY: 37AN XY: 111034
GnomAD3 exomes
AF:
AC:
96
AN:
202772
Hom.:
AF XY:
AC XY:
37
AN XY:
111034
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000249 AC: 353AN: 1414942Hom.: 2 Cov.: 31 AF XY: 0.000199 AC XY: 140AN XY: 703322
GnomAD4 exome
AF:
AC:
353
AN:
1414942
Hom.:
Cov.:
31
AF XY:
AC XY:
140
AN XY:
703322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00265 AC: 404AN: 152174Hom.: 1 Cov.: 31 AF XY: 0.00242 AC XY: 180AN XY: 74432
GnomAD4 genome
AF:
AC:
404
AN:
152174
Hom.:
Cov.:
31
AF XY:
AC XY:
180
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
DYNLT2B-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 23, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at